Health & Conditions

94 articles

All articles →
Health & Conditions

Vitamin D Toxicity: What 50,000 IU Daily Actually Does to Your Body

Vitamin D toxicity is rare but real—reported cases usually involve very high doses, often tens of thousands of IU daily for weeks to months, causing dangerous calcium buildup that can damage the kidneys. The adult upper limit is 4,000 IU a day.

11 min read
Health & Conditions

Lowering CRP With Diet: What the Evidence Actually Shows

Diet can lower hs-CRP modestly: Mediterranean-style eating cut it by about 1 mg/L in trials, and each kilogram of weight lost lowers it by roughly 0.13 mg/L. No specific food combination is proven to slash it, and results above 10 mg/L need a doctor's review.

11 min read
Health & Conditions

Morning Joint Stiffness: What Those First 30 Minutes Can Tell You

Morning stiffness lasting more than 30-60 minutes is more typical of inflammatory joint conditions, while shorter stiffness points toward mechanical issues—tracking it helps you spot patterns worth discussing with a doctor.

9 min read
Health & Conditions

GLP-1 for PCOS: Semaglutide, Weight & Ovulation (2026)

GLP-1 medications for PCOS are used off-label — they are not FDA-approved for polycystic ovary syndrome itself. By driving weight loss and improving insulin resistance, drugs like semaglutide (Ozempic, Wegovy) can help restore ovulation and more regular cycles in some women, but they require medical supervision and are not for use in pregnancy.

6 min read
Health & Conditions

Low Stomach Acid (Hypochlorhydria): Real Causes, Signs, and What the Evidence Says

Low stomach acid is mostly caused by atrophic gastritis, H. pylori and long-term acid-suppressing medicines rather than age alone, and it can lead to B12 and iron deficiency. Symptoms can't reliably tell low acid from high acid, and popular natural remedies have little evidence—testing and treating the cause matter most.

10 min read
Health & Conditions

GLP-1 for Menopause: Weight Gain, Belly Fat & Muscle (2026)

GLP-1 for menopause is used to treat the weight gain and visceral belly fat that often accompany the menopause transition — not menopause itself. Drugs like semaglutide (Ozempic, Wegovy) can reduce weight and abdominal fat, but a portion of the loss is muscle, so protein and strength training are essential to protect midlife muscle and bone.

5 min read
Health & Conditions

What Vitamin D Level Actually Supports Your Immune System? What the Evidence Shows

There's no trial-proven "immune-optimal" vitamin D level. Correcting a real deficiency matters, but pooled trials now show no statistically significant reduction in respiratory infections overall, and the 2024 Endocrine Society guideline advises against routine testing and above-standard doses in healthy adults under 75.

11 min read
Health & Conditions

GLP-1 Period Changes, Fatigue & Hot Flashes (2026)

On a GLP-1 (semaglutide — Ozempic, Wegovy; or tirzepatide — Mounjaro, Zepbound), period changes and hot flashes are mostly indirect — driven by weight loss, hormone shifts, and midlife menopause overlap, not a direct drug action — while fatigue is a recognized side effect tied to eating less, dehydration, and low blood sugar. Track them; verify causes with your clinician.

6 min read
Health & Conditions

Blood Pressure Variability Day to Day: What's Normal and When to Worry

Blood pressure naturally rises and falls through the day. What matters most is your average over several days of home readings (hypertension starts at 135/85 mmHg at home) and the pattern—night-time dipping, morning surges and long-term variability.

9 min read
Health & Conditions

GLP-1 for Perimenopause: Weight Gain & Insulin (2026)

GLP-1 for perimenopause is used to treat the weight gain, rising insulin resistance, and belly fat that begin during the transition years — often while you are still having periods — not perimenopause itself. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) can help, but protein and strength training are essential because perimenopause is when lean-muscle loss accelerates.

5 min read
Health & Conditions

GLP-1 Postpartum: Breastfeeding Safety & Weight (2026)

GLP-1s are not recommended while breastfeeding. The US Wegovy (semaglutide) label advises against breastfeeding with Wegovy tablets and calls for a benefit–risk decision for the injection, the EU label says semaglutide should not be used while breastfeeding, and clinical guidance advises avoiding tirzepatide while nursing. GLP-1s must also be stopped in pregnancy. Any use for postpartum weight loss is an individual decision to make with your OB-GYN — usually only once you are no longer breastfeeding.

4 min read

Ready for Smarter Weight Loss?

Everything you need to lose weight, preserve muscle, and build healthier habits—all in one AI-powered app.

Download on the App StoreGet it on Google Play

Free to download. In-app purchases may apply.